Effectively managing high cholesterol level and safely lowering LDL-C is crucial for preventing and reducing the risk of adverse cardiovascular events. However, achieving LDL-C goals remains suboptimal, particularly in high-risk and very high-risk patients. The landscape of lipid lowering therapy has significantly evolved, with new consensus statements, newer agents, and important evidence that may help address some current gaps. This three part series consists of 3 cases that illustrate important concepts in managing patients with familial hypercholesterolemia, patients with hyperlipidemia and cardiometabolic comorbidities, and patient with South Asian descent with increased risk of ASCVD and a history of percutaneous Intervention. The cases are designed to be quick and offer high-level takeaways and pearls. In this Ace the Case Challenge you will review Case #2 – A 62-Year-Old Diabetic Woman with an LDL-C of 53 mg/dL. Once you have completed this activity and claimed credit, be sure to view the other cases in this series.
- Provider:Partners for Advancing Clinical Education (PACE)
- Activity Link: https://cme.tarsusmedicaleducation.com/cardiometabolic-health-congress-cmhc-/content/ace-case-2-62-year-old-diabetic-woman-ldl-c-53-mgdl
- Start Date: 2024-06-12 05:00:00
- End Date: 2024-06-12 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Novartis Corporation Pharmaceuticals - Amount: 34900.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all